NIAID is committed to the research necessary to successfully end HIV/AIDS. Each year, 50,000 people in the United States become infected with HIV, the virus that causes AIDS. Currently, there are an estimated 1.1 million people in the United States and 34 million people globally who are living with HIV infection. In 2011, 1.7 million people died from AIDS-related causes. Through our laboratories and clinics at the National Institutes of Health to our vast network of supported research at universities, medical centers, and clinical trial sites around the globe, NIAID is working to better understand HIV and how it causes disease, find new tools to prevent HIV infection, develop new and more effective treatments for HIV-infected people, and find a cure.
Large-Scale HIV Vaccine Trial to Launch in South Africa | see Q&A—May 18, 2016
NIH Statement on HIV Vaccine Awareness Day—May 18, 2016
Media Availability: NIH-Led Team Discovers New HIV Vaccine Target—May 12, 2016
Bulletin: AIDS-Kaposi’s Sarcoma Study Ended—May 5, 2016
Media Availability: Single Antibody Infusions Provide Durable Protection Against HIV-Like Virus in Monkeys—April 27, 2016
News From NIAID-Supported Institutions
Last Updated May 18, 2016